Lilly Falls on Oral Obesity Pill as FDA Decision Looms
Eli Lilly stock fell about 5% as investors awaited the FDA's April decision on orforglipron. Novo Nordisk's intensifi...
Review today’s 30-year mortgage rate chart to compare trends and identify favorable rates across lenders.
23,821 articlesEli Lilly stock fell about 5% as investors awaited the FDA's April decision on orforglipron. Novo Nordisk's intensifi...
A Gulf-region conflict, surging oil prices, and a payroll standoff for TSA workers collide with spring travel demand,...
A 73-year-old worker with an $800,000 401(K) cannot roll it into a new IRA after leaving a former employer, revealing...
The Invesco QQQM ETF offers a low-cost way to ride tech gains, but a handful of mega-caps shape most of its outcomes,...
For the first time in decades, Berkshire Hathaway held its annual meeting without Warren Buffett. Executives laid out...
AppLovin rode a stronger-than-expected Q1 to lift expectations for its AI-focused ad platform. Margin gains and robus...
Chip stocks are rising on AI infrastructure strength even as software names sag, hinting at a broader market rotation...
In a market flooded with messages, brands that project clear, trusted signals win. This report explains how have stro...
Piper Sandler just hiked Humana's price target to $254 after a strong Q1 and improving Medicare Advantage margins, si...
HSBC upgraded Cisco to Buy and lifted the price target as the company moves toward a $6 billion AI revenue goal for F...
A wave of healthcare AI players trading under $50 is drawing attention for real progress in partnerships and revenue....
California's mom-and-pop shops face shrinking profits as energy, labor, and regulatory costs rise, prompting tougher ...